Breaking News, Financial News

Financial Report: BioClinica

Revenues up 13% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioClinica 2Q Revenues: $23.1 million (+13%) 2Q Earnings: $1.0 million (+12%) YTD Revenues: $45.7 million (+14%) YTD Earnings: $2.0 million (+59%) Comments: Service revenues increased 13% to $19.1 million. Operating income was $3.3 million, compared to $2.0 million, including a restructuring charge of $679,000 in 2Q11. Backlog of $110.2 million was down from $112.5 million in 2Q11 due to the cancellation of a large drug program due to lack of efficacy. Mark L. Weinstein, president and chief...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters